COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$54.17
−14.67%Price chart
Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10
ValuationView details →
P/E (Fwd)
11.1x
EV/EBITDA
15.9x
Market Cap
$10.56B
MomentumView details →
1D Return
−14.67%
YTD Return
−33.38%
RSI (14)
14.9
ValuationView details →
P/E (Fwd)
11.1x
EV/EBITDA
15.9x
Market Cap
$10.56B
RSI (14)
14.9
MomentumView details →
1D Return
−14.67%
YTD Return
−33.38%
SummaryUpdated Jul 1, 2026
The Cooper Companies, Inc. (NYSE:COO) is a global medical device company founded in 1958 and headquartered in San Ramon, California. The company has evolved from its origins into a leading manufacturer of contact lenses and women's healthcare products. Cooper Companies went public in 1983 and has grown through strategic acquisitions and organic expansion to become a significant player in the medical devices industry, operating in over 100 countries worldwide with annual revenues approaching $4 billion.
Similar companies
Latest newsMore news →
Cooper Cos. wrapped up a strategic review without plans to seek a deal.7h agoU.S. stocks opened broadly lower on September 10, with the Dow Jones Industrial Average down 195 points (0.4%), the S&P 500 down 0.6% and the Nasdaq down 0.9%, as oil topped $100 a barrel and inflation worries intensified.9h agoCooper Companies guided Q4 (August-October) adjusted EPS to $1.05-$1.09 and revenue to $1.06-$1.08 billion, below analyst estimates of $1.19 and $1.11 billion respectively.10h ago